SternAegis
51
19M
27
4.25
6
0.43
13
- Stages of investment
- Areas of investment
Summary
SternAegis Ventures appeared to be the VC, which was created in 2012. The main department of described VC is located in the New York. The venture was found in North America in United States. SternAegis Ventures seemed to be an CVC arrangement as part of the organization.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this SternAegis Ventures performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2013.
Among the most popular portfolio startups of the fund, we may highlight Deem, MATINAS BIOPHARMA, PROLOR Biotech. We can highlight the next thriving fund investment areas, such as Medical Device, Information Technology. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
We also calculated 2 valuable employees in our database.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the SternAegis Ventures, startups are often financed by Spencer Trask & Co., JP Morgan Chase & Co., American Express. The meaningful sponsors for the fund in investment in the same round are Soleus Capital Management, RTW Investments LLC, Perceptive Advisors. In the next rounds fund is usually obtained by Oak Investment Partners, Molex Ventures, Foundation Capital.
Investments analytics
Analytics
- Total investments
- 51
- Lead investments
- 6
- Exits
- 13
- Rounds per year
- 4.25
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (26)
- Health Care (21)
- Medical (18)
- Therapeutics (15)
- Medical Device (12) Show 45 more
- Investments by region
-
- United States (41)
- India (3)
- Israel (2)
- Canada (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 73M
- Group Appearance index
- 0.12
- Avg. company exit year
- 7
- Avg. multiplicator
- 0.72
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Captify | 15 Jul 2013 | Marketing, Advertising, Digital Entertainment | Early Stage Venture | 1M | United Kingdom, London, England |
| Super League Gaming | 12 Oct 2022 | Gaming, eSports, Video Games | Early Stage Venture | 32M | United States, California, Santa Monica |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.